|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenues: | |
| License revenue | |
| Total revenue | |
| Operating expenses: | |
| Research and development | |
| General and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Other income, net: | |
| Change in fair value of convertible preferred stock forward | |
| Interest income | |
| Other expense, net | |
| Total other income, net | |
| Net loss | |
| Net loss attributable to common stockholders | |
| Basic net loss per share of common stock | |
| Diluted net loss per share of common stock | |
| Weighted average basic shares of common stock outstanding | |
| Weighted average diluted shares of common stock outstanding |
Loading...
